Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Miyamoto

Showing results (141-150 of 219) with videos related to

Pageof 22
Sort By:
Biology of Reproduction|March 25, 2005
Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell lineKotaro Fukushima, Shingo Miyamoto, Kiyomi Tsukimori, et al.
Anticancer Research|August 30, 2011
Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemiaNaoko Kunami, Fusanori Yotsumoto, Kenji Ishitsuka, et al.
Scientific Reports|April 19, 2019
Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer preventionShingo Miyamoto, Takumi Narita, Masami Komiya, et al.
Cureus|April 1, 2024
Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot StudyFusanori Yotsumoto, Kenichi Yoshikawa, Toyofumi Hirakawa, et al.
Biochemical and Biophysical Research Communications|November 21, 2007
Validation of HB-EGF and amphiregulin as targets for human cancer therapyFusanori Yotsumoto, Hiroshi Yagi, Satoshi O Suzuki, et al.
Anticancer Research|June 30, 2016
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Japanese Journal of Clinical Oncology|November 20, 2018
Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancerShingo Miyamoto, Ryutaro Nomura, Kengo Sato, et al.
Thoracic Cancer|September 5, 2019
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancerMari Tone, Takehiro Izumo, Nobuyasu Awano, et al.
Human Molecular Genetics|September 6, 2014
DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulationKohei Miyata, Tomoko Miyata, Kazuhiko Nakabayashi, et al.
Journal of Clinical Biochemistry and Nutrition|June 7, 2017
Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumorsTakahiro Hamoya, Shingo Miyamoto, Susumu Tomono, et al.
Pageof 22

Showing results (141-150 of 219) with videos related to

Sort By:
Pageof 22
Biology of Reproduction|March 25, 2005
Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell lineKotaro Fukushima, Shingo Miyamoto, Kiyomi Tsukimori, et al.
Anticancer Research|August 30, 2011
Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemiaNaoko Kunami, Fusanori Yotsumoto, Kenji Ishitsuka, et al.
Scientific Reports|April 19, 2019
Novel screening system revealed that intracellular cholesterol trafficking can be a good target for colon cancer preventionShingo Miyamoto, Takumi Narita, Masami Komiya, et al.
Cureus|April 1, 2024
Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot StudyFusanori Yotsumoto, Kenichi Yoshikawa, Toyofumi Hirakawa, et al.
Biochemical and Biophysical Research Communications|November 21, 2007
Validation of HB-EGF and amphiregulin as targets for human cancer therapyFusanori Yotsumoto, Hiroshi Yagi, Satoshi O Suzuki, et al.
Anticancer Research|June 30, 2016
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer TherapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Japanese Journal of Clinical Oncology|November 20, 2018
Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancerShingo Miyamoto, Ryutaro Nomura, Kengo Sato, et al.
Thoracic Cancer|September 5, 2019
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancerMari Tone, Takehiro Izumo, Nobuyasu Awano, et al.
Human Molecular Genetics|September 6, 2014
DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulationKohei Miyata, Tomoko Miyata, Kazuhiko Nakabayashi, et al.
Journal of Clinical Biochemistry and Nutrition|June 7, 2017
Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumorsTakahiro Hamoya, Shingo Miyamoto, Susumu Tomono, et al.
Pageof 22